PDGFRB and central nervous system cancer: A study by Ho et al. revealed the anti-angiogenic role of MSCs, which can be attributed to reduced expression of platelet-derived growth factor (PDGF/PDGFR), one of the well-known axes in glioma angiogenesis [109].